These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8195450)

  • 1. Blood pressure and heart rate response of panic disorder patients receiving imipramine in a dose-response treatment paradigm.
    de Groot CM; Mavissakalian MR
    J Clin Psychopharmacol; 1994 Apr; 14(2):107-10. PubMed ID: 8195450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
    Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
    Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
    Mavissakalian MR; Perel JM
    Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response characterization of the antipanic effects of imipramine.
    Mavissakalian MR; Perel JM
    Psychopharmacol Bull; 1994; 30(2):171-4. PubMed ID: 7831451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and blood pressure: significance of the law of initial values.
    Yeragani VK; Meiri PC; Pohl R; Balon R; Merlos B
    Pharmacopsychiatry; 1990 Nov; 23(6):279-82. PubMed ID: 2284330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R; Hosmane B; Bonacci E; O'Dea R
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
    Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
    Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder.
    Lydiard RB; Morton WA; Emmanuel NP; Zealberg JJ; Laraia MT; Stuart GW; O'Neil PM; Ballenger JC
    Psychopharmacol Bull; 1993; 29(2):183-8. PubMed ID: 8290663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension.
    Thase ME; Haight BR; Johnson MC; Hunt T; Krishen A; Fleck RJ; Modell JG
    J Clin Psychopharmacol; 2008 Jun; 28(3):302-7. PubMed ID: 18480687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day.
    Rodríguez-Roa E; Octavio A; Mayorca E; Castro P; Miranda R; Valecillo E; González M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S151-5. PubMed ID: 11986915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia.
    Auerbach SM; Gittelman M; Mazzu A; Cihon F; Sundaresan P; White WB
    Urology; 2004 Nov; 64(5):998-1003; discussion 1003-4. PubMed ID: 15533493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of imipramine treatment on heart rate variability measures.
    Yeragani VK; Pohl R; Balon R; Ramesh C; Glitz D; Weinberg P; Merlos B
    Neuropsychobiology; 1992; 26(1-2):27-32. PubMed ID: 1475036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.